In an article titled “Amazon MGM Studios’ Debra Birnbaum Joins Ovarian Cancer Research Alliance Board,” Variety editor William Earl writes about MGM Studios’ Debra Birnbaum’s appointment to Ovarian Cancer Research Alliance’s board of directors. An ovarian cancer survivor, Debra Birnbaum talks about what inspired her to join OCRA, and what she hopes to accomplish for those impacted by the disease.
Related Topics
OCRA-Funded ROCCA Platform Launches to Accelerate Rare Ovarian Cancer Research
OCRA is proud to announce the launch of the Rare Ovarian Cancer Collaborative Analytics (ROCCA) Platform, an international federated data network funded by OCRA to connect researchers globally and accelerate breakthroughs in rare ovarian cancer research. A collaborative approach to research for rare ovarian cancer ROCCA is launching with two foundational projects: one in mucinous … Continued
We’re Changing How Cancer Research Happens
We Believe There’s a Better Way to Do Research So we created it. OCRA has launched the most ambitious initiative in our history. We believe it represents a fundamentally new way for research to work—one with the potential to accelerate discovery in gynecologic cancers while serving as a model for breakthroughs across all diseases. We … Continued
Ovarian Cancer Research Alliance Launches Community Accelerated Research Exchange, a Global AI-Powered Ecosystem to Transform Gynecologic Cancer Research
Platform, powered by AWS, connects patients, researchers, and clinicians to accelerate breakthroughs in gynecologic cancers [NEW YORK, NY – May 8, 2026] — Ovarian Cancer Research Alliance (OCRA) today announced the launch of the Community Accelerated Research Exchange, a first-of-its-kind, global, AI-powered ecosystem designed to transform how gynecologic cancer research is conducted—accelerating breakthroughs by connecting … Continued
